Detoxifying capacity and kinetics of the molecular adsorbent recycling system: Contribution of the different inbuilt filters

Blood Purification

Volumn 21, Issue 3, 2003, Pages 244-252

  Evenepoel, Pieter ^a   Maes, Bart ^a   Wilmer, Alexander ^a   Nevens, Frederik ^a   Fevery, Johan ^a   Kuypers, Dirk ^a   Bammens, Bert ^a   Vanrenterghem, Yves ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Albumin dialysis; Albumin bound toxins; Liver failure

Indexed keywords

ALBUMIN; ANION EXCHANGE RESIN; BILE ACID; BILIRUBIN; CHARCOAL; CREATININE; TOXIN; UREA;

ADULT; AGED; ARTICLE; BILE ACID BLOOD LEVEL; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DETOXIFICATION; DIALYSATE LEVEL; DIALYSIS MEMBRANE; FEMALE; HEMODIALYSIS; HUMAN; KINETICS; LIVER FAILURE; LIVER NECROSIS; LONG TERM CARE; MALE; MOLECULAR ADSORBENT RECYCLING SYSTEM; PRIORITY JOURNAL; SHORT COURSE THERAPY; STATISTICAL SIGNIFICANCE; UREA BLOOD LEVEL;

ADULT; AGED; ANION EXCHANGE RESINS; BILIRUBIN; BLOOD CHEMICAL ANALYSIS; FEMALE; HEMOPERFUSION; HUMANS; KINETICS; LIVER DISEASES; MALE; MIDDLE AGED; RENAL DIALYSIS; SENSITIVITY AND SPECIFICITY; TOXINS, BIOLOGICAL; TREATMENT OUTCOME;

EID: 0038693558     PISSN: 02535068     EISSN: None     Source Type: Journal    
DOI: 10.1159/000070697     Document Type: Article

References (27)

1. Gill RQ, Sterling RK: Acute liver failure. J Clin Gastroenterol 2001;33:191-198.
2. Secher A, Osorio J, Freise C, Osorio RW: Artificial liver support devices for fulminant liver failure. Clin Liver Dis 2001;5:415-430.
3. Rahman TM, Hodgson HJF: Review article: Liver support systems in acute hepatic failure. Aliment Pharmacol Ther 1999;13:1255-1272.
4. Kramer L, Gendo A, Madl C, Ferrara I, Funk G, Schenk P, Sunder-Plassmann G, Hörl WH: Biocompatibility of a cuprophane charcoal-based detoxification device in cirrhotic patients with hepatic encephalopathy. Am J Kidney Dis 2000;36:1193-1200.
5. Ash SR: Biocompatibility of sorbent suspension dialysis in cirrhotic patients with hepatic encephalopathy. Am J Kidney Dis 2001;38:219-220.
6. O'Grady JG, Gimson AES, O'Brien CJ, Pucknell A, Hughes RD, Williams R: Controlled trials of charcoal hemoperfusion and prognostic factors in fulminant hepatic failure. Gastroenterology 1988;94:1186-1192.
7. Kreymann B, Seige M, Schweigart U, Kopp KF, Classen M: Albumin dialysis: Effective removal of copper in a patient with fulminant Wilson disease and successful bridging to liver transplantation. A new possibility for the elimination of protein-bound toxins. J Hepatol 1999;31:1080-1085.
8. Stange J, Mitzner SR, Risler T, Erley CM, Lauchart W, Goehl H, Klammt S, Peszynski P, Freytag J, Hickstein H, Löhr S, Liebe S, Schareck W, Hopt UT, Schmidt R: Molecular adsorbent recycling system (MARS): Clinical results of a new membrane-based blood purification system for bioartificial liver support. Artif Org 1999;23:319-330.
9. Mitzner SR, Stange J, Klammt S, Peszynski P, Schmidt R, Nödlge-Schomburg G: Extracorporeal detoxification using the molecular adsorbent recirculating system for critically ill patients with liver failure. J Am Soc Nephrol 2001;12:S75-S82.
10. Stange J, Mitzner SR, Klammt S, Freytag J, Peszynski P, Loock J, Hickstein H, Korten G, Schmidt R, Hentschel J, Schulz M, Löhr M, Liebe S, Schareck W, Hopt T: Liver support by extracorporeal blood purification: A clinical observation. Liver Transplant 2000;6:603-613.
11. Mitzner SR, Stange J, Klammt S, Risler T, Erley CM, Bader BD, Berger ED, Lauchart W, Peszynski P, Freytag J, Hikstein H, Loock J, Löhr JM, Liebe S, Emmric J, Korten G, Schmidt R: Improvement of hepatorenal syndrome with extracorporeal albumin dialysis MARS: Results of a prospective, randomized, controlled clinical trial. Liver Transplant 2000;6:277-286.
12. Falkenhagen D, Strobl W, Vogt G, Schrefl A, Linsberger I, Gerner FJ, Schoenhofen M: Fractionated plasma separation and adsorption system: A novel system for blood purification to remove albumin bound substances. Artif Org 1999;23:81-86.
13. Novelli G, Rossi M, Pretagostini R, Poli L, Per-itore D, Berloco P, Di Nicuolo A, Lapelli M, Cortesini R: Use of MARS in the treatment of acute liver failure: Preliminary monocentric experience. Transplant Proc 2001;33:1942-1944.
14. Sorkine P, Abraham RB, Szold O, Biderman P, Kidron A, Merchav H, Brill S, Oren R: Role of the molecular adsorbent recycling system (MARS) in the treatment of patients with acute exacerbation of chronic liver failure. Crit Care Med 2001;29:1332-1336.
15. Stange J, Hassanein TI, Mehta R, Mitzner SR, Bartlett RH: The molecular adsorbents recycling system as a liver support system based on albumin dialysis: A summary of preclinical investigations, prosepctive, randomized, controlled clinical trial, and clinical experience from 19 centers. Artif Organs 2002;26:103-110.
16. Verbeke G, Molenberghs G: Linear Mixed Models for Longitudinal Data. New York, Springer, 2000.
17. Wilmer A, Nevens F, Evenepoel P, Hermans G, Fevery J: The molecular adsorbent recycling system in patients with severe liver failure: Clinical results at the K.U. Leuven. Liver 2002; 22(suppl 2):52-55.
18. Awad SS, Swaniker F, Magee J, Punch J, Bartlett RH: Results of a phase I trial evaluating a liver support device utilizing albumin dialysis. Surgery 2001;130:354-362.
19. Schmidt LE, Sorensen VR, Svendsen LB, Hansen BA, Larsen FS: Hemodynamic changes during a single treatment with the molecular adsorbents recirculating system in patients with acute-or-chronic liver failure. Liver transplantation 2001;7:1034-1039.
20. Weiss JS, Gautam A, Lauff JJ, Sundberg MW, Jatlow P, Boyer JL, Seligson DN: The clinical importance of a protein-bound fraction of serum bilirubin in patients with hyperbilirubinemia. N Engl J Med 1983;309:147-150.
21. Chadha V, Garg U, Warady BA, Alon US: Sieving coefficient inaccuracies during hemodiafiltration in patients with hyperbilirubinemia. Pediatr Nephrol 2000;15:33-35.
22. Roda A, Capelleri G, Aldini R, Roda E, Barbara L: Quantitative aspects of the interaction of bile acids with human serum albumin. J Lipid Res 1982;23:490-495.
23. Mamianetti A, Tripodi V, Vescina C, Garrido D, Vizioli N, Carducci C, Carreno CA: Serum bile acids and pruritus in hemodialysis patients. Clin Nephrol 2000;53:194-198.
24. Yamaga N, Adachi K, Shimizu K, Miyaka S, Sumi F, Miyagawa Y, Goto H: Bile acids of patients with renal failure receiving chronic hemodialysis. Steroids 1986;48:427-438.
25. Stange J, Mitzner S: A carrier-mediated transport of toxins in a hybrid membrane: Safety barrier between a patients blood and a bioartificial liver. Int J Artif Organs 1996;19:677-691.
26. Klammt S, Brinkmann B, Mitzner S, Munzert E, Loock J, Stange J, Emmrich J, Liebe S: Albumin binding capacity (AbiC) is reduced in commercially available human serum albumin preparations with stabilizers. Z Gastroenterol 2001;39:24-27.
27. Lesaffer G, De Smet R, Lameire N, Dhondt Annemieke, Duym P, Vanholder R: Intradialytic removal of protein-bound uraemic toxins: Role of solute characteristics and of dialyser membranes. Nephrol Dial Transplant 2000;15: 50-57.